Omeprazole Delayed Release Tablets, 20 mg | Omeprazole

15:06 EDT 22nd May 2015 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Purpose Acid reducer

Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.  These may be signs of a serious condition.  See your doctor.

Ask a doctor before use if you have

Ask a doctor or pharmacist before use if you are taking

Stop use and ask a doctor if

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.(1-800-2221222)

Inactive ingredients carnauba wax, ferric oxide red, ferric oxide yellow, hypromellose, hypromellose acetate succinate, lactose monohydrate, monoethanolamine, propylene glycol, sodium lauryl sulfate, sodium starch glycolate, sodium stearate, sodium stearyl fumarate, talc, titanium dioxide, triethyl citrate

IMAGE 14ct_inner_carton_label.jpgIMAGE bottle_label.jpgIMAGE 70ct_carton.jpg

84 Tablets

OMEPRAZOLE DR TABLETS 20MG OTCAcid Reducer

FOR REPACKAGING ONLY

Manufactured by:Dexcel Pharma Technologies Ltd.10 Hakidma Street, Hi-Tech Park,Yokneam, 20692, Israel

Manufacturer

Dexcel Pharma Technologies Ltd.

Active Ingredients

Source

Drugs and Medications [102 Associated Drugs and Medications listed on BioPortfolio]

Omeprazole [Dexcel Pharma Technologies Ltd.]

Omeprazole Delayed Release Tablets, 20 mg

Prilosec otc [Procter & Gamble Manufacturing Company]

Prilosec OTC omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer

Prilosec otc [Physicians Total Care, Inc.]

Prilosec OTC omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer

Members mark omeprazole [Sam's West Inc]

Sam's West, Inc. Omeprazole Delayed Release Tablets 20 mg Drug Facts

Zegerid otc [MSD Consumer Care, Inc.]

Zegerid OTC

Clinical Trials [99 Associated Clinical Trials listed on BioPortfolio]

Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

The purpose of this study is to compare the blood drug levels of two prescribed medications, immediate-release omeprazole 40 mg powder and delayed-release omeprazole 40 mg capsule to deter...

Drug Interaction Study With Proton Pump Inhibitor

The purpose of this clinical research study is to assess the effect of omeprazole at 20 mg on the pharmacokinetics of atazanavir administered as atazanavir with ritonavir relative to ataza...

Sopran - Omeprazole Treatment Versus Surgery

The purpose of this study is to study gastritis, GI symptoms during long term omeprazole treatment

Evaluation of Omeprazole Effect on Glaucoma

Omeprazole is a safe drug listed in OTC drug due to its safety. It acts by irreversible inhibition of K/H ATP ase pump and also Na/K ATP ase, Na/H ATP ase.Considering these actions the ef...

Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions

An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover oral bioequivalence study of Omeprazole Magnesium 20 mg DR capsules of Dr. Reddy's Labo...

PubMed Articles [31 Associated PubMed Articles listed on BioPortfolio]

Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse.

The objectives were to document the pharmacokinetics of intravenous, enteric-coated oral and plain oral omeprazole in fasted horses and to investigate the impact of feeding on the bioavailability of a...

Is it necessary to increase the dose of levothyroxine in patients with hypothyroidism who use omeprazole?

Objective It is believed that gastric pH interferes in levothyroxine absorption. Omeprazole, which acts by blocking the secretion of gastric acid, might interfere in hypothyroidism control in patients...

Effect of Omeprazole on the Pharmacokinetics of Rosuvastatin in Healthy Male Volunteers.

The current study aimed at the evaluation of, in vivo, the effect of omeprazole on the pharmacokinetics of rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. Omeprazo...

Pharmacokinetics and bioequivalence testing of five commercial formulations of omeprazole in the horse.

Omeprazole is widely used in the treatment of equine gastric ulcer syndrome. To date, little is known about the relative pharmacokinetics of the different formulations making comparisons between produ...

Omeprazole, A Gastric Proton Pump Inhibitor, Inhibits Melanogenesis by Blocking ATP7A Trafficking.

Omeprazole is a proton pump inhibitor (PPI) used in the treatment of peptic ulcer disease and gastrosophageal reflux disease and acts by irreversibly blocking ATP4A, a P-type H+/K+ ATPase in gastric p...

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Pain
Latest News Clinical Trials Research Drugs Reports Corporate
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Food
Latest News Clinical Trials Research Drugs Reports Corporate
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record